Delivery Order SPE2DB20D3103-SPE2DB24FM5Y9
Award Date
2/8/24
Potential Completion Date
2/9/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LYUMJEV 100 UNIT/ML VIAL 10ML. The contract, which has a firm fixed price of $1,032.09 and a period of performance through August 8, 2024, was not set aside for any specific business category. As a key supplier to various federal agencies, AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,773.57, is for the delivery of LYUMJEV 100 UNIT/ML VIAL 10ML, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 5, 2023. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and holds a significant...
This federal contract award is for the delivery of LYUMJEV 100 UNIT/ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,291.63 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 5, 2024 with a performance period ending on August 6, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,116.13 firm fixed-price delivery order is for the supply of LYUMJEV 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a period of performance through April 23, 2024. Amerisourcebergen Drug Corporation holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Lyumjev 100 Unit/mL Vial 10mL, a pharmaceutical product. The award, valued at $1,296.36, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of September 18, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,485.96 firm-fixed-price contract is for the supply of LYUMJEV 100 UNIT/ML KWIKPEN 3ML, a medication used for diabetes management. The contract has a period of performance through March 5, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $3,334.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of LYUMJEV 100 UNIT/ML KWIKPEN 3ML, a specialty medication, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,315.66 firm fixed price delivery order to provide LYUMJEV 100 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support...
The Defense Logistics Agency awarded a $800 delivery order to Amerisourcebergen Drug Corporation for LYUMJEV 100 unit/ml vials. As the prime contractor, Amerisourcebergen will deliver 10 ml vials of the diabetes medication to a facility in Conshohocken, Pennsylvania within a firm fixed price contract starting August 11th and concluding on the 14th of 2023. The Defense Logistics Agency utilizes contracts such as this to efficiently procure necessary medical supplies for the U.S. Department of...
The Defense Logistics Agency awarded a $748.57 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561806015 LYUMJEV 100 UNIT/ML VIAL 10ML. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products from its location in Conshohocken, Pennsylvania to the Defense Logistics Agency between August 14-15, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of...